ロード中...
The Treatment of IgA Nephropathy
BACKGROUND: IgA nephropathy (IgAN) is a very common glomerulonephritis worldwide. Nevertheless, treatment options for primary IgAN are still largely based on opinion or weak evidence. There is a lack of large randomized controlled trials (RCT) that provide a definitive immunosuppressive protocol for...
保存先:
| 出版年: | Kidney Dis (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4934817/ https://ncbi.nlm.nih.gov/pubmed/27536661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000381508 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|